Dimitri Yavordios

Title: Innovations of Dimitri Yavordios

Introduction

Dimitri Yavordios is a notable inventor based in Chatillon sur Chalaronne, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiallergic compounds. With a total of 5 patents to his name, Yavordios continues to push the boundaries of innovation in his field.

Latest Patents

Yavordios's latest patents include the development of antiallergic 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-one compounds. These compounds are characterized by a formula where R₁ is a straight-chain, branched, or cyclic alkyl group with up to 6 carbon atoms, and Z is an alkylene chain with 2 to 4 carbon atoms. The compounds exhibit pharmacological properties, particularly antiallergic effects. Another significant patent involves 1-phenylindazol-3-one compounds, which serve as useful intermediates in synthesizing 1-phenyl-2-[(4-substituted piperazinyl) alkyl]-1,2-dihydro-3H-indazol-3-ones, also known for their antiallergic activity.

Career Highlights

Dimitri Yavordios is currently associated with Kali-Chemie Pharma GmbH, where he applies his expertise in pharmaceutical innovation. His work has been instrumental in advancing the development of new therapeutic agents that address allergic conditions.

Collaborations

Yavordios collaborates with esteemed colleagues such as Daniel Jasserand and Henning Heinemann, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Dimitri Yavordios stands out as a prominent inventor in the pharmaceutical industry, with a focus on developing innovative antiallergic compounds. His contributions continue to impact the field positively, showcasing the importance of research and collaboration in driving advancements in healthcare.